PDF
(Download)
|
- Aloe Vera (Aloe vera, Xanthorrhoeaceae)
- Diabetes
- Hypolipidemic Effects
|
Date:
10-31-2016 | HC# 101661-555
|
Re: Review of the Hypoglycemic and Hypolipidemic Effects of Aloe Vera
Pothuraju
R, Sharma RK, Onteru SK, Singh S, Hussain SA. Hypoglycemic and hypolipidemic effects
of Aloe vera extract preparations: a
review. Phytother Res. February 2016;30(2):200-207.
Type
2 diabetes is often associated with alterations in metabolism, free fatty acid
accumulation, inflammation, and oxidative stress. There are several standard pharmaceutical
treatments; however, they may not treat all associated symptoms and may cause
adverse side effects. Aloe vera (Aloe
vera, Xanthorrhoeaceae) has been used traditionally in many countries
throughout the world for skin ailments and gastrointestinal problems. This
review highlights studies on the potential use of aloe vera to treat diabetes
and its symptoms.
Aloe
vera contains anthraquinones, phytosterols, carbohydrates, and other bioactive
compounds. Phytosterols have been found to aggregate cholesterol, resulting in
lower systemic cholesterol levels. A polysaccharide called acemannan has been
shown to have anti-inflammatory effects via the activation of cytokines. In mice
with diabetes, aloe vera phytosterols significantly decreased both fasting
blood glucose concentrations and glycated hemoglobin (HbA1c). In rats with
diabetes, 300 mg/kg of an ethanolic extract of aloe vera elevated insulin
concentrations and normalized blood glucose levels. This extract also resulted
in lower lipid, cholesterol, and kidney triglyceride concentrations.
Aloe
vera extract at 0.5% and 1% weight per volume was shown to increase the count
of Lactobacillus casei, a potentially
beneficial species of gut microbiota. In diabetic rats, a water extract
modulated the activity of an enzyme critical to gluconeogenesis and lowered
lipid peroxidase activity. Phytosterols in aloe vera increased the expression
of peroxisome proliferator-activated receptor-gamma and -alpha (PPARγ and PPARα,
respectively), as well as many other genes upstream of metabolic processes,
such as fatty acid oxidation and gluconeogenesis, in obese mice. In cells, aloe
vera extract activated glucose transporter type 4 (GLUT4) expression, the
protein transporter involved in glucose uptake.
There
have been several clinical trials for aloe vera's potential use in treating
diabetes. Patients with diabetes taking a fraction of aloe vera containing
acemannan and the glycoprotein verectin three times per day for 12 weeks were
shown to have lowered fasting blood glucose and triglyceride concentrations.
The mechanism of this activity is thought to be due to the attenuation of
glucose absorption from acemannan's metabolites. Those with diabetes taking one
600-mg capsule daily of aloe vera leaf gel had lowered blood glucose, total
cholesterol, and low-density lipoprotein (LDL) cholesterol concentrations.
In
those with prediabetes or early diabetes, aloe vera gel consumption for eight
weeks lowered body weight, fat mass, fasting blood glucose, and insulin
concentrations. Patients with diabetes taking aloe vera gel powder at 100 mg
and 200 mg for three months [it is assumed daily] had a decrease in fasting and
fed glucose, blood pressure, triglycerides, and total and LDL cholesterol
concentrations. In another study of aloe vera extract administered at 300 and
500 mg twice daily for eight weeks in patients with prediabetes, those taking
300 mg had significantly lower fasting blood glucose concentrations, while
those taking 500 mg had decreased HbA1c, total cholesterol, and LDL cholesterol
levels.
In
a study in patients with diabetes, 60 days of 600 mg per day of aloe vera
extract did not result in any adverse side effects on kidney or liver
functions. In another 12-week trial, aloe vera fractions did not cause adverse
side effects; however, aloe vera was thought to cause diarrhea and vomiting in a
separate study.
Although
many of these studies suggest that aloe vera may be efficacious in treating
diabetes, it is mentioned that various extracts and preparations showed different
bioactivity. The authors state that future work investigating aloe vera whole
extract is necessary for determining mechanisms of action.
—Amy C. Keller, PhD
|